Black Diamond Therapeutics BDTX
NASDAQ BDTX
$1.96 -0.14 (-6.67%)
As of: Sep 10, 2026 · 3:59 PM EDT

Black Diamond Therapeutics (BDTX) Prepaid Assets (2018 - 2026)

Black Diamond Therapeutics' (BDTX) quarterly Prepaid Assets came in at $4.9 million in Q2 2026, up 25.43% on a YoY basis from $3.9 million in Q2 2025, and up 3.8% quarter-over-quarter from $4.7 million in Q1 2026.

Analysis

Black Diamond Therapeutics (BDTX) Prepaid Assets (2018 - 2026) Analysis & Trends

Black Diamond Therapeutics (BDTX) has reported Prepaid Assets for 9 consecutive years, with $4.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets rose 25.43% year-over-year to $4.9 million; the trailing twelve-month figure through Jun 2026 stood at $4.9 million (up 25.43% YoY), and the FY2025 full-year result was $3.8 million, up 45.64% from the prior year.
  • Prepaid Assets advanced to $4.9 million in Q2 2026 per BDTX's latest filing, from $4.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.6 million in Q1 2022 and bottomed at $2.6 million in Q4 2024.
  • Historically, Prepaid Assets has averaged $4.4 million across 5 years, with a median of $3.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets tumbled 58.91% in 2023, then soared 45.64% in 2025.
  • Over 5 years, Prepaid Assets stood at $4.9 million in 2022, then sank by 46.23% to $2.6 million in 2023, then slipped by 1.25% to $2.6 million in 2024, then jumped by 45.64% to $3.8 million in 2025, then rose by 29.04% to $4.9 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $4.9 million, $4.7 million, and $3.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Black Diamond Therapeutics 111.58 Mn 1.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.89 Mn
Mar 31, 2026 4.71 Mn
Dec 31, 2025 3.79 Mn
Sep 30, 2025 3.49 Mn
Jun 30, 2025 3.90 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.60 Mn
Sep 30, 2024 2.86 Mn
Jun 30, 2024 3.78 Mn
Mar 31, 2024 3.61 Mn
Dec 31, 2023 2.63 Mn
Sep 30, 2023 2.79 Mn
Jun 30, 2023 3.47 Mn
Mar 31, 2023 4.61 Mn
Dec 31, 2022 4.90 Mn
Sep 30, 2022 6.80 Mn
Jun 30, 2022 7.67 Mn
Mar 31, 2022 8.57 Mn
Dec 31, 2021 5.92 Mn
Sep 30, 2021 6.54 Mn